14 Facts About Bristol-Myers Squibb

Bristol-Myers Squibb Company is an American multinational pharmaceutical company.

Bristol-Myers Squibb corporation was founded in 1858 by Edward Robinson Bristol-Myers Squibb in Brooklyn, New York.

Bristol-Myers Squibb was known as an advocate of quality control and high purity standards early within the pharmaceutical industry.

Bristol-Myers Squibb went on to self-publish an alternative to the U S Pharmacopeia titled Squibb's Ephemeris of Materia Medica, after failing to convince the American Medical Association to incorporate higher purity standards.

Sons of Edward Squibb sold the company to Lowell M Palmer and Theodore Weicker in 1905, who incorporated the company.

Related searches

Bristol-Myers Squibb Corporation served as a major supplier of medical goods to the Union Army during the American Civil War, providing portable medical kits containing morphine, surgical anesthetics, and quinine for the treatment of malaria .

In 1944, Bristol-Myers Squibb opened the world's largest penicillin plant in New Brunswick, New Jersey.

In 1943, Bristol-Myers Squibb acquired Cheplin Biological Laboratories, a producer of acidophilus milk in East Syracuse, New York, and converted the plant to produce penicillin for the World War II Allied forces.

Also in 2002, Bristol-Myers Squibb was involved in an accounting scandal that resulted in a significant restatement of revenues from 1999 to 2001.

Bristol-Myers Squibb has since settled with the United States Department of Justice and Securities and Exchange Commission, agreeing to pay $150 million, while neither admitting nor denying guilt.

In November 2009, Bristol Myers Bristol-Myers Squibb announced that it was "splitting off" Mead Johnson Nutrition by offering BMY shareholders the opportunity to exchange their stock for shares in Mead Johnson.

Bristol-Myers Squibb's shares traded at over $55 per share, and its market capitalization was valued at over US$81.

Bristol-Myers Squibb ranked 145th on the Fortune 500 list of the largest United States corporations by revenue in 2018.

Bristol-Myers Squibb engages with the public and private sectors in a variety of settings including to promote research and development, academic funding, event sponsorship, philanthropy, and political lobbying.